Abiraterone Abirapro 250mg: API Sourcing and GMP Supply with Prednisone

Overview

Abiraterone is a CYP17 lyase inhibitor for prostate cancer that must be paired with low-dose prednisone, and its reliable supply starts with the active ingredient. Consistent, high-purity API and registered GMP manufacturing let clinics receive bioequivalent tablets with dependable batch quality and traceability. For B2B buyers, the sourcing story matters as much as the pharmacology: a stable GMP pipeline avoids the disruptions that could interrupt long-term therapy. The 250 mg tablet builds the standard daily dose from a fixed count, which keeps dispensing accurate across busy pharmacy workflows.

How It Works

Abiraterone blocks the CYP17 enzyme in the adrenal glands and tumor tissue, cutting the synthesis of androgens at the source. This lowers the intracrine androgen that continues to fuel castration-resistant prostate cancer even after testosterone is suppressed. Because blocking CYP17 also raises ACTH and mineralocorticoid excess, concurrent prednisone is required to prevent fluid and electrolyte complications while androgen suppression continues, so the drug and steroid are effectively one combined regimen.

Indications

• Metastatic castration-resistant prostate cancer, with prednisone
• Metastatic high-risk castration-sensitive prostate cancer, with ADT and prednisone
• Used where continued androgen suppression is the goal

Dosage & Administration

The dose is 1000 mg once daily, four 250 mg tablets, taken with prednisone 5 mg twice daily. It is taken on an empty stomach: no food for two hours before and one hour after the dose. Tablets are swallowed whole with water, and the prednisone cover continues throughout treatment to manage mineralocorticoid effects, because even short gaps in steroid cover can permit sudden fluid retention or hypokalemia. Patients are counselled to keep the fasting window consistent, since food markedly raises absorption and changes overall drug exposure.

Storage & Sourcing

Store below 30°C in a dry place. Sourced from Glenmark GMP lines with lot-specific certificates of analysis and registration. As an ambient-stable oral solid with no cold-chain need, it suits broad B2B distribution to pharmacies supporting prostate cancer programs, and verified batch records keep every shipment auditable from factory to patient.

FAQ

Q: Why are sourcing and GMP important here?

A: Abiraterone needs consistent, high-purity API and registered GMP manufacturing so clinics receive bioequivalent tablets with reliable batch quality and traceability.

Q: Why must prednisone be given with it?

A: Blocking CYP17 raises ACTH and mineralocorticoid excess; low-dose prednisone prevents fluid and electrolyte problems while androgen suppression continues.

Q: How is it taken?

A: 1000 mg once daily, four 250 mg tablets, on an empty stomach with prednisone 5 mg twice daily, and no food around the dose.

Q: What storage and batch controls apply?

A: Keep below 30°C dry, with no cold chain; verified certificates of analysis and batch records make every shipment auditable from factory to patient.